Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.

BMC neurology - 23 Feb 2017

Tai Shu-Yu, Chen Chun-Hung, Chien Chen-Yu, Yang Yuan-Han

Abstract excerpt

BACKGROUND: Combination therapy using acetylcholinesterase inhibitors (AChEIs) and cilostazol is of unknown efficacy for patients with Alzheimer's disease (AD). METHODS: We explored the therapeutic responses by using a case-control study, which was conducted in Taiwan. We enrolled 30 participants with stable AD who were receiving cilostazol (50 mg) twice per day as an add-on therapy combined with AChEIs, and 30...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins E
Share to Cholinesterase Inhibitors
Share to Cognition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Neuroprotective Agents

Share to Neuropsychological Tests

Share to Taiwan

Share to Tetrazoles

Source

Open in PubMed Open full text

Identifiers

PMID: 28231822
DOI: 10.1186/s12883-017-0800-y
PMCID: PMC5324327

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.PMID 28231822Read ↗

Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-world DataSemantic proximity Read ↗

Treatment effects of pharmacotherapy and non-pharmacotherapy of Alzheimer dementia: A systematic review overview and updated network meta-analysis.Semantic proximity Read ↗

Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease.Semantic proximity Read ↗

Association of the choline acetyltransferase gene with responsiveness to acetylcholinesterase inhibitors in Alzheimer's disease.Semantic proximity Read ↗

Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.Semantic proximity Read ↗

[Effect of anticholinergic drugs on cognitive impairment in the elderly].Semantic proximity Read ↗

Association between ABCA1 gene polymorphisms and the therapeutic response to donepezil therapy in Han Chinese patients with Alzheimer's disease.Semantic proximity Read ↗

Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease.Semantic proximity Read ↗

Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Association of CHAT Gene Polymorphism rs3793790 and rs2177370 with Donepezil Response and the Risk of Alzheimer's Disease Continuum.Semantic proximity Read ↗

Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.